Compounded Semaglutide Online: Fast Access from $149/mo

Compounded semaglutide is a prescription medication prepared by US-licensed compounding pharmacies using the same active ingredient found in brand-name Ozempic and Wegovy. Compounding pharmacies create customized formulations under strict regulatory oversight, allowing for greater flexibility in dosing and delivery methods.

Unlike brand-name medications that come in fixed-dose pens from a single manufacturer, compounded semaglutide can be prepared in various formulations — including injectable, oral liquid, and combination formulas with supportive ingredients like vitamin B12.

VivioMD partners with US-licensed compounding pharmacies including RedRock (UT), Health Warehouse (KY), Triad RX (AL), and Precision Compounding (NY) to deliver compounded semaglutide directly to patients across all 50 states.

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. It works through multiple mechanisms to support weight loss:

• Appetite reduction: Signals to the brain that you're full, reducing hunger and cravings
• Slowed gastric emptying: Food moves through your stomach more slowly, helping you feel satisfied longer
• Improved insulin sensitivity: Helps regulate blood sugar levels, which can reduce fat storage

In the STEP clinical trials, patients taking semaglutide achieved an average weight loss of 12-15% of their body weight over 68 weeks. Individual results may vary.

VivioMD offers compounded semaglutide at a flat rate of $149/mo at any dose. Unlike other providers that increase pricing as your dose increases, VivioMD maintains the same price throughout your treatment.

• No insurance required
• No membership or enrollment fees
• No hidden costs or surprise charges
• HSA/FSA eligible
• Cancel anytime

Compare this to brand Ozempic at $900-1,400+/mo without insurance, or brand Wegovy at similar prices. For a cost-focused alternative, see our Ozempic alternatives guide. Also interested in tirzepatide? See our tirzepatide pricing breakdown.

Semaglutide treatment follows a gradual titration schedule to minimize side effects. A typical progression looks like:

• Weeks 1-4: Starting dose (lowest level to assess tolerance)
• Weeks 5-8: Increased dose based on tolerance and response
• Weeks 9+: Continued titration toward target maintenance dose

Your VivioMD clinician will determine your specific dosing schedule based on your health profile, response, and goals. Doses are never adjusted without clinical oversight.

The most common side effects of semaglutide are gastrointestinal and typically subside as your body adjusts:

• Nausea — most common, especially during dose titration
• Decreased appetite — an expected effect of the medication
• Digestive changes — diarrhea, constipation, or abdominal discomfort
• Injection site reactions — for injectable forms, mild redness or irritation

Semaglutide carries a boxed warning about thyroid C-cell tumors observed in animal studies. It is not recommended for patients with a personal or family history of medullary thyroid cancer or MEN2.

For full eligibility and safety information, see our eligibility and safety guide.